Medical News

---

• Extreme psoriasis increases mortality risk, not through CVD
• UK acute upper GI bleed rates declining
• UK acute upper GI bleed rates declining
• Longer INR follow-up interval linked to worse anticoagulation control
• Third ventricle involvement predicts ICH outcomes
• Tamoxifen compliance low in younger breast cancer survivors
• Combination therapy reduces sPLA2 activity
• Dietary advice can reduce saturated fat intake in children
• Angiography patients often have undetected diabetes and IGT
• Microvascular risk differs with gender and age at onset of Type 1 diabetes
• Use of evidence-based STEMI treatments cuts mortality risk
• Morning MIs linked to larger infarct size
• Tamoxifen compliance low in younger breast cancer survivors

Extreme psoriasis increases mortality risk, not through CVD Posted: 28 Apr 2011 05:00 PM PDT Patients with "exceptionally severe" psoriasis have an increased mortality risk compared with those with less extreme forms of the condition, but as a result of diseases other than cardiovascular disease, report researchers.

UK acute upper GI bleed rates declining Posted: 28 Apr 2011 05:00 PM PDT Findings from a 2007 UK audit show that rates of acute upper gastrointestinal bleeding have fallen by 4% since 1993.

UK acute upper GI bleed rates declining Posted: 28 Apr 2011 05:00 PM PDT Findings from a 2007 UK audit show that rates of acute upper gastrointestinal bleeding have fallen by 4% since 1993.

Longer INR follow-up interval linked to worse anticoagulation control Posted: 27 Apr 2011 05:00 PM PDT The interval between an initial out-of-range international normalized ratio value and a repeat test varies widely from clinic to clinic, even though long follow-up intervals are associated with worse anticoagulation control, US researchers report.

Third ventricle involvement predicts ICH outcomes Posted: 27 Apr 2011 05:00 PM PDT The volume of blood in the third ventricle is strong predictor of outcome in patients with intracerebral hemorrhage with severe ventricular involvement, research shows.

Tamoxifen compliance low in younger breast cancer survivors Posted: 27 Apr 2011 05:00 PM PDT Approximately half of women under 40 years of age with breast cancer discontinue tamoxifen therapy within 5 years of treatment initiation, study findings indicate.

Combination therapy reduces sPLA2 activity Posted: 27 Apr 2011 05:00 PM PDT Treatment with atorvastatin plus ezetimibe can significantly reduce the activity of secretory phospholipase A2 in patients with coronary artery disease, study results show.

Dietary advice can reduce saturated fat intake in children Posted: 27 Apr 2011 05:00 PM PDT Australian researchers say that promoting the consumption of reduced-fat dairy foods can significantly reduce saturated fat, but not energy, intake in children.

Angiography patients often have undetected diabetes and IGT Posted: 27 Apr 2011 05:00 PM PDT Previously undetected impaired glucose tolerance and Type 2 diabetes are common in patients undergoing angiography for suspected angina, suggest study results.

Microvascular risk differs with gender and age at onset of Type 1 diabetes Posted: 27 Apr 2011 05:00 PM PDT The risk for developing microvascular complications in adulthood among people with Type 1 diabetes is highly dependent on gender and age-at-onset of diabetes, say researchers.

Use of evidence-based STEMI treatments cuts mortality risk Posted: 27 Apr 2011 05:00 PM PDT The increasing use of evidence-based, guideline-recommended treatments for ST-elevation myocardial infarction has been accompanied by "large and sustained" reductions in mortality, an analysis of Swedish registry data reveals.

Morning MIs linked to larger infarct size Posted: 27 Apr 2011 05:00 PM PDT Infarct size varies according to the time of day that an ST-segment elevation myocardial infarction occurs, research from Spain suggests.

Tamoxifen compliance low in younger breast cancer survivors Posted: 27 Apr 2011 05:00 PM PDT Approximately half of women under 40 years of age with breast cancer discontinue tamoxifen therapy within 5 years of treatment initiation, study findings indicate.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610